c-Myc and HIF1A are the two well-known master regulators of metabolic networks including energy metabolism, deregulations of which are recognized now as one of the “hallmarks of cancer.” Enhanced glycolysis in malignant cells is associated with tumor progression, migration, invasion, and resistance against chemo- and radiotherapy. This evidence concerns the gene MYC and cancer.